Telmisartan/Esamlodipine Tablets 80/5 mg

Adult dose

The recommended dose of this medication is 1 tablet once daily, taken with water regardless of meals. It is advisable to take it at the same time each day (e.g., in the morning). Patients with renal impairment do not require dosage adjustment for mild to moderate renal impairment, but patients with severe renal impairment should start with a lower dose and gradually increase it. The daily dose for patients with liver impairment should not exceed 40 mg.

Child dose

Safety and efficacy in pediatric patients under the age of 18 have not been established, so the administration of this medication is not recommended.

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus and newborn. If pregnancy is confirmed, this medication should be discontinued immediately, and alternative treatment methods should be sought. This medication should not be administered to patients with allergies to its active ingredients or related compounds, those with certain liver, heart, or kidney diseases, pregnant or nursing women, and patients with certain other conditions. Special caution is advised when using this medication in patients with specific heart valve diseases, impaired liver function, gastrointestinal diseases, kidney diseases, the elderly, etc., and it should be taken cautiously under the direction of a physician. While taking this medication, side effects such as headache, dizziness, edema, palpitations, gastrointestinal disturbances may occur, and if any abnormal symptoms appear, immediate consultation with medical personnel is required. Taking this medication during pregnancy can result in serious issues such as reduced fetal kidney function, decreased amniotic fluid, and skull formation disorders, so if planning pregnancy or already pregnant, it is essential to consult with a doctor. In nursing mothers, this medication may be transmitted through breast milk, so nursing should be discontinued or this medication should be avoided. It is not recommended for children as safety and efficacy have not been sufficiently established. When administered to the elderly, the dosage should be adjusted and carefully monitored as physical reactions may be more sensitive. In cases of overdose, severe hypotension, dizziness, and arrhythmias may occur, and it is necessary to visit a medical institution immediately for appropriate treatment. This medication may interact with other drugs, so if you are taking any other medications, be sure to inform your healthcare provider. Caution should be exercised as dizziness or drowsiness may occur when driving or operating machinery. This medication should be kept out of reach of children and should not be transferred to other containers.

Serious side effects

• Severe allergic reactions: Angioedema (could result in fatal outcomes)
• Severe skin adverse reactions: Exfoliative dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis
• Respiratory issues: Asthma, shortness of breath
• Liver issues (jaundice): Yellowing of skin or eyes (jaundice), liver dysfunction and liver disease, increased jaundice and liver enzyme levels
• Severe neurological symptoms: Seizures, confusion
• Severe swelling or urination issues: Angioedema, decreased urine output

Mild side effects

• Headache
• peripheral edema
• swelling
• palpitations
• dizziness
• increased SGOT
• nausea
• increased platelets
• facial flushing
• local edema

This medication should be stored in a tightly closed container to prevent air and moisture from entering. It is recommended to store it at room temperature between 1 to 30 degrees Celsius.

Appearance

Pale yellow and pale blue bi-layered oblong tablets

Package unit

30 tablets/bottle